Aeglea BioTherapeutics Inc. focuses on developing and commercializing human enzyme therapeutics for the treatment of rare genetic diseases. The company’s objective is to leverage current comprehensive capabilities and technologies to build a sustainable pipeline of enzyme-based therapies targeting specific diseases with unmet medical needs.
Notification